Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Clinical investigations in the EU: changes and challenges

This article was originally published in Clinica

Executive Summary

Medical device manufacturers are faced with a major challenge in keeping up to date with the profusion of developments that are occurring in Europe with the regulation of clinical investigations. Many changes have recently been made or are in the process of being made, both at European level and at national level, Danielle Giroud, founder and president of d-Target, told a recent Management Forum meeting in London on February 2 on GCP for Medical Devices in Europe. And manufacturers would be wise to monitor these changes, since they have a huge impact on the variation in conditions for carrying out clinical investigations in each country, writes Amanda Maxwell





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts